Invited Faculty
  • Chandra Mohan
    Univ. of Houston
    USA
  • Following his medical training in Pathology and Rheumatology at the National University of Singapore and the Singapore General Hospital in Singapore, Dr. Mohan undertook his doctoral thesis work focusing on the cellular immunology of lupus at Tufts University, Boston. His post-doctoral training focused on the genetic analysis of murine lupus. As an independent investigator, his laboratory’s research efforts have concentrated on elucidating the cellular, molecular, and genetic players leading to murine lupus nephritis, with corresponding translational studies in human lupus nephritis. His more recent work has focused on translating findings from basic biology towards the early diagnosis of end-organ involvement in autoimmune diseases. Dr. Mohan’s ongoing studies are aimed at tapping leads from proteomic platforms to mine new biomarkers and targets in chronic rheumatic diseases, notably lupus nephritis, and to apply the latest bioengineering technologies to advance the management of these ailments. He currently holds the Cullen Distinguished Professorship at the University of Houston, in Houston, TX. Dr. Mohan is an elected member of the American Society of Clinical Investigation.
    Research & Clinical Focus

    Lupus

    Biomarkers

    Proteomics

    Immunology

    Bioengineering

    • Date Time Room Session Title Lecture Title
    May 18 13:20-13:40 Room Grand Ballroom 101 [Concurrent Session 2] Biomarkers from Bench to Bedside The quest for end organ focused biomarkers in SLE